Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders Summit took place on July 6th, 2015 and concluded on July 8th, 2015. The event was ...

Narcan Revives Victims of Potentially Fatal Overdose, but Cannot Curb Addictive Behaviors; Harbor Village Detox Introduces Incentive Program for Substance Use Disorders

USA (PRWEB) April 13, 2015 The addiction treatment industry is holding Naloxone and Narcan in high regard, based upon its recent performance to resuscitate victims of opiate overdoses. Narcan is a drug which temporarily reverses the deadly effect of fatal overdoses. Addiction professionals are hopeful Narcan will give drug addicts a new perspective on life ...

Exoskeleton System Market in Military and for Orthopedic Disorders to 2019 Forecast a New Research Report at ReportsnReports.com

Dallas, Texsa (PRWEB) February 09, 2015 One of the major trends in the Exoskeleton System Market is the development of an exoskeleton-mounted computer system for soldiers. The US military has awarded several exoskeleton R&D project contracts to various robotic companies and research institutes in the Americas. The exoskeleton empowers the soldiers to easily lift the ...

Rett Syndrome Research Trust Awards $5.8 Million to Advance the Development of Treatments and Cures for Rett Syndrome and MECP2 Disorders

Rett Syndrome Research Trust Awards $5.8 Million to Advance the Development of Treatments and Cures for Rett Syndrome and MECP2 Disorders
Trumbull, CT (PRWEB) February 03, 2015 Today the Rett Syndrome Research Trust (RSRT) announced research investments of $ 5.8 million awarded in 2014. RSRT’s sole and urgent goal is to abolish Rett Syndrome and related disorders. To that end, RSRT has awarded $ 25 million to research since its launch in 2008. Rett Syndrome ...

New Research Shows Music Listening Therapy Can Help People with Autism Spectrum Disorders

New Research Shows Music Listening Therapy Can Help People with Autism Spectrum Disorders
Ogden, Utah (PRWEB) January 29, 2015 Sensory processing disorder (SPD), defined by the study as an inability to process “incoming sensory stimuli, determine its meaning, and generate a response consistent with the context,” is a common component of ASD. In addition, sensory over-responsivity (SOR) is a subtype of SPD that makes it difficult for a ...

Wimbledon U Responsible for Saving Student Athletes Lives through Diagnostic Testing: Severe cardiac disorders uncovered through cutting edge testing at D1 Universities

Wimbledon U Responsible for Saving Student Athletes Lives through Diagnostic Testing: Severe cardiac disorders uncovered through cutting edge testing at D1 Universities
Boca Raton, FL (PRWEB) January 19, 2015 Wimbledon Health Partners, through its collegiate testing division Wimbledon U, delivers on-site diagnostic testing that provides colleges and universities both vascular imaging and echocardiography. The primary focus in conducting this type of testing is to discover underlying symptoms related to coronary artery disease, Marfan syndrome, sudden cardiac arrest, ...

Wellcome Trust Sanger Institute: Project pinpoints 12 new genetic causes of developmental disorders

(PRWEB UK) 24 December 2014 Embargoed until 18:00 UK time on Wednesday 24 December, 2014 The first results to emerge from a nationwide project to study the genetic causes of rare developmental disorders have revealed 12 causative genes that have never been identified before. The Deciphering Developmental Disorders (DDD) project, the world’s largest, nationwide ...

Catalent and Valerion Therapeutics Collaborate to Bring New Treatments for Orphan Genetic Disorders to Market

Somerset, N.J. (PRWEB) December 02, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to collaborate with Valerion Therapeutics, LLC, an emerging science-driven company, focused on the development of bio-therapeutics for orphan genetic diseases, to develop Valerion’s ...

Sanford Study Reveals Fetal Alcohol Spectrum Disorders Prevalence in U.S.

Sanford Study Reveals Fetal Alcohol Spectrum Disorders Prevalence in U.S.
SIOUX FALLS, S.D. (PRWEB) October 30, 2014 Nearly 5 percent of U.S. children may be affected by fetal alcohol spectrum disorders, according to a new study co-authored by Sanford Research’s Gene Hoyme, M.D., and Amy Elliott, Ph.D., and published by Pediatrics. The study, “Prevalence and characteristics of fetal alcohol spectrum disorders,” explored the incidence ...